Skip to content

Pharminent

cropped-banner_frontpage_2026-07-11-2.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Clinical Data
  • Pivotal trial of Moderna’s H5N1 bird flu jab gets underway
  • Clinical Data

Pivotal trial of Moderna’s H5N1 bird flu jab gets underway

Pharmaphorum

The first volunteers in a large-scale trial of Moderna's mRNA-based vaccine against bird flu have received shots in the UK and US.

Clinical DataInfectious DiseaseRead full story

pharminent April 22, 2026 (Last updated: April 22, 2026)

Pharmaphorum

The first volunteers in a large-scale trial of Moderna’s mRNA-based vaccine against bird flu have received shots in the UK and US.

Clinical DataInfectious DiseaseRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: BioAegis and Prenosis partner for inflammatory disease therapies
Next: New data build case for Roche’s oral BTK drug for MS

Related Stories

  • Clinical Data

AstraZeneca, Ionis drug fails big heart disease study in major setback

pharminent July 9, 2026
  • Clinical Data

Roche’s KRAS drug tops its rivals in lung cancer trial

pharminent July 2, 2026
  • Clinical Data

EAN 2026: Real-world data supports safety and efficacy of AbbVie’s Vyalev in Parkinson’s

pharminent July 1, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.